Recursion to Participate in Upcoming Investor Conferences
Recursion (Nasdaq: RXRX) will participate in multiple investor conferences in March 2026, presenting company updates and management outlooks.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Recursion (Nasdaq: RXRX) will participate in multiple investor conferences in March 2026, presenting company updates and management outlooks.
Scheduled events include TD Cowen (March 2), Leerink Partners (March 9), Jefferies Biotech on the Beach (March 11), and KeyBanc Healthcare Forum (March 17). Webcasts are available in the events section at the company investor relations site.
Details
News Market Reaction – RXRX
On Feb 23, the day this news came out, RXRX closed 0.29% below the previous close.
Data tracked by StockTitan Argus for the Feb 23 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Salt Lake City, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:
- TD Cowen 46th Annual Healthcare Conference - Monday, March 2, 2026
- Leerink Partners 2026 Global Healthcare Conference - Monday, March 9, 2026
- Jefferies 2026 Biotech on the Beach Summit — Wednesday, March 11, 2026
- KeyBanc 2026 Healthcare Forum — Tuesday, March 17, 2026
Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.recursion.com, or connect on X and LinkedIn.

Investor Contact investor@recursion.com Media Contact media@recursion.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.